195 related articles for article (PubMed ID: 32925406)
21. Current Open Trials and Molecular Update for Pediatric Embryonal Tumors.
Rosenberg T; Cooney T
Pediatr Neurosurg; 2023; 58(5):299-306. PubMed ID: 37245504
[TBL] [Abstract][Full Text] [Related]
22. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
23. [A new entity in WHO classification of tumors of the central nervous system--embryonic tumor with abundant neuropil and true rosettes: case report and review of literature].
Ryzhova MV; Zheludkova OG; Ozerov SS; Shishkina LV; Panina TN; Gorelyshev SK; Novikov AI; Melikian AG; Kushel' IuV; Korshunov AE
Zh Vopr Neirokhir Im N N Burdenko; 2011; 75(4):25-33; discussion 33. PubMed ID: 22379850
[TBL] [Abstract][Full Text] [Related]
24. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Fuller CE; Jones DTW; Kieran MW
Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
[TBL] [Abstract][Full Text] [Related]
26. Embryonal tumors of the central nervous system.
Pagès M; Masliah-Planchon J; Bourdeaut F
Curr Opin Oncol; 2020 Nov; 32(6):623-630. PubMed ID: 32890024
[TBL] [Abstract][Full Text] [Related]
27. Significance and therapeutic value of miRNAs in embryonal neural tumors.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Molecules; 2014 May; 19(5):5821-62. PubMed ID: 24806581
[TBL] [Abstract][Full Text] [Related]
28. Medulloblastomas, CNS embryonal tumors, and cerebellar mutism syndrome: advances in care and future directions.
Patel N; Keating G; Solanki GA; Syed HR; Keating RF
Childs Nerv Syst; 2023 Oct; 39(10):2633-2647. PubMed ID: 37632526
[TBL] [Abstract][Full Text] [Related]
29. A review of recently described genetic alterations in central nervous system tumors.
Lucas CG; Solomon DA; Perry A
Hum Pathol; 2020 Feb; 96():56-66. PubMed ID: 31678207
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.
Braoudaki M; Lambrou GI
J Hematol Oncol; 2015 Feb; 8():6. PubMed ID: 25652781
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Int J Mol Sci; 2014 Nov; 15(11):21554-86. PubMed ID: 25421247
[TBL] [Abstract][Full Text] [Related]
32. Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis: Clinicopathologic Analysis of 23 Cases.
Murdock T; Orr B; Allen S; Ibrahim J; Sharma R; Ronnett BM; Rodriguez FJ
Am J Surg Pathol; 2018 Nov; 42(11):1429-1444. PubMed ID: 30074494
[TBL] [Abstract][Full Text] [Related]
33. The 2007 WHO classification of tumors of the central nervous system - what has changed?
Rousseau A; Mokhtari K; Duyckaerts C
Curr Opin Neurol; 2008 Dec; 21(6):720-7. PubMed ID: 18989119
[TBL] [Abstract][Full Text] [Related]
34. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.
MacDonald TJ; Rood BR; Santi MR; Vezina G; Bingaman K; Cogen PH; Packer RJ
Oncologist; 2003; 8(2):174-86. PubMed ID: 12697942
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathology of paediatric central nervous system tumours.
Chiang JC; Ellison DW
J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
[TBL] [Abstract][Full Text] [Related]
36. Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.
Penas-Prado M
Am Soc Clin Oncol Educ Book; 2017; 37():187-191. PubMed ID: 28561706
[TBL] [Abstract][Full Text] [Related]
37. Four Levels of Diagnosis in the Rare Pediatric Embryonal Tumor of the CNS Called Embryonal Tumor with Multilayered Rosettes.
Frazier AA
Radiographics; 2018; 38(2):524. PubMed ID: 29528833
[No Abstract] [Full Text] [Related]
38. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.
Korshunov A; Sturm D; Ryzhova M; Hovestadt V; Gessi M; Jones DT; Remke M; Northcott P; Perry A; Picard D; Rosenblum M; Antonelli M; Aronica E; Schüller U; Hasselblatt M; Woehrer A; Zheludkova O; Kumirova E; Puget S; Taylor MD; Giangaspero F; Peter Collins V; von Deimling A; Lichter P; Huang A; Pietsch T; Pfister SM; Kool M
Acta Neuropathol; 2014 Aug; 128(2):279-89. PubMed ID: 24337497
[TBL] [Abstract][Full Text] [Related]
39. World Health Organization 2016 Classification of Central Nervous System Tumors.
Diamandis P; Aldape K
Neurol Clin; 2018 Aug; 36(3):439-447. PubMed ID: 30072064
[TBL] [Abstract][Full Text] [Related]
40. Embryonal and non-meningothelial mesenchymal tumors of the central nervous system - Advances in diagnosis and prognostication.
Meredith DM; Alexandrescu S
Brain Pathol; 2022 Jul; 32(4):e13059. PubMed ID: 35266242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
